4
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Mapping Theme Trends and Research Frontiers in Dexmedetomidine Over Past Decade: A Bibliometric Analysis

ORCID Icon, , , , , , , , ORCID Icon & ORCID Icon show all
Pages 3043-3061 | Received 13 Jan 2024, Accepted 04 Jul 2024, Published online: 23 Jul 2024

Figures & data

Figure 1 PRISMA flowchart of the study.

Figure 1 PRISMA flowchart of the study.

Figure 2 Bibliometric analysis of publication outputs. (A) The number of annual publications. (B) The distribution of publications by countries/regions.

Figure 2 Bibliometric analysis of publication outputs. (A) The number of annual publications. (B) The distribution of publications by countries/regions.

Table 1 The Top 10 Countries/Regions and Institutions Involved in Dexmedetomidine

Figure 3 Cooperation between countries/regions on dexmedetomidine. (A) The cooperation networks between different countries/regions; (B) Countries/regions cross-chord charts; (C) Geography map of countries/regions for dexmedetomidine.

Figure 3 Cooperation between countries/regions on dexmedetomidine. (A) The cooperation networks between different countries/regions; (B) Countries/regions cross-chord charts; (C) Geography map of countries/regions for dexmedetomidine.

Figure 4 Cooperation between institutions on dexmedetomidine. (A) The cooperation networks between different institutions; (B) The top 10 institutions in count; (C) The top 10 institutions in centrality.

Figure 4 Cooperation between institutions on dexmedetomidine. (A) The cooperation networks between different institutions; (B) The top 10 institutions in count; (C) The top 10 institutions in centrality.

Table 2 The Top 10 Authors and Cited Authors in Dexmedetomidine

Figure 5 Authors analysis on dexmedetomidine. (A) The cooperation networks between different authors; (B) The density visualization map of authors based on VOSviewer; (C) The cooperation networks between different cited authors.

Figure 5 Authors analysis on dexmedetomidine. (A) The cooperation networks between different authors; (B) The density visualization map of authors based on VOSviewer; (C) The cooperation networks between different cited authors.

Table 3 According to Bradford’s Law, the 1,186 Journals in Dexmedetomidine were Classified into Zones 1–3

Figure 6 Journals analysis on dexmedetomidine. (A) Journals output trends within the top 5 from 2014 to 2023; (B) Core journals by Bradford’s law.

Figure 6 Journals analysis on dexmedetomidine. (A) Journals output trends within the top 5 from 2014 to 2023; (B) Core journals by Bradford’s law.

Table 4 The Top 10 Cited Journals in Dexmedetomidine

Figure 7 Cited journals analysis on dexmedetomidine. (A) The network map of cited journals; (B) The top 10 cited journals in count; (C) The top 10 cited journals in centrality; (D) The dual-map overlay of citing of citation relationship of articles, with citing journal on the left, and the cited journal on the right. The colored path represented the citation relationship.

Figure 7 Cited journals analysis on dexmedetomidine. (A) The network map of cited journals; (B) The top 10 cited journals in count; (C) The top 10 cited journals in centrality; (D) The dual-map overlay of citing of citation relationship of articles, with citing journal on the left, and the cited journal on the right. The colored path represented the citation relationship.

Table 5 The Top 10 Cited References in Dexmedetomidine

Figure 8 Cited references analysis on dexmedetomidine. (A) The network map of cited references; (B) The clustering of cited references; (C) The top 30 cited references with the strongest citation bursts.

Figure 8 Cited references analysis on dexmedetomidine. (A) The network map of cited references; (B) The clustering of cited references; (C) The top 30 cited references with the strongest citation bursts.

Table 6 Top 10 Productive WOS Categories in Dexmedetomidine, Ranked by the Number of Publications

Figure 9 R bibliometrics-thematic evolution tool traces the progression of research themes in the realm of dexmedetomidine, spanning from 2014 to 2023.

Notes: The time segmentation points were established by R in 2018, 2020 and 2022.
Figure 9 R bibliometrics-thematic evolution tool traces the progression of research themes in the realm of dexmedetomidine, spanning from 2014 to 2023.

Figure 10 Keywords analysis on dexmedetomidine. (A) The network map of the co-occurrence keywords; (B) Clusters of keywords; (C) Timeline view of keywords analysis; (D) The top 20 keywords with the strongest citation bursts.

Figure 10 Keywords analysis on dexmedetomidine. (A) The network map of the co-occurrence keywords; (B) Clusters of keywords; (C) Timeline view of keywords analysis; (D) The top 20 keywords with the strongest citation bursts.

Data Sharing Statement

The datasets used or analyzed during the current study are available from the corresponding author on reasonable request.